AI Governance for Healthcare
AI Governance Readiness for Healthcare Organizations
AI is already in your documentation, scheduling, analytics, and revenue-cycle tools — often through vendors, not internal projects. This short, fixed-scope review shows where AI is actually in use, how it touches PHI, and whether your governance and documentation would stand up to OCR, payer, or buyer scrutiny.
60–90 minutes · Leave with clear AI governance priorities, not a sales pitch
Why AI governance can’t wait for “future regulations”
Most healthcare AI exposure doesn’t begin with internal AI projects. It starts when EHRs, transcription tools, scheduling platforms, and analytics vendors quietly embed AI before governance processes have caught up. Regulators have said existing laws still apply: HIPAA, OCR’s discrimination guidance, and evolving security requirements all extend to AI-enabled systems that handle PHI.
For boards, executives, and PE operators, the key question is simple: “If someone asks us to defend how we use AI, can we?” That means knowing where AI is in your workflows, what it touches, and how it is governed today — not someday.
Most organizations are earlier in their AI governance maturity than they think. The goal of this review is not perfection — it is visibility, defensibility, and a clear next step.
- Healthcare organizations where staff or vendors already use AI in documentation, scheduling, triage, analytics, or revenue cycle.
- Leaders worried about OCR, payer, or plaintiff scrutiny around AI-influenced decisions and PHI handling.
- PE operators who need a defensible view of AI risk in diligence or portfolio governance.
Scope: a focused look at how AI is really used today
The AI Governance Readiness Review is a short, fixed-scope engagement built around four questions:
- 01
Where is AI actually in use?
Internal tools, third-party vendors, embedded EHR features, and ad-hoc use of general-purpose AI.
- 02
What data and processes does it touch?
PHI flows, training-data exposure, access paths, and links to HIPAA Security Rule safeguards.
- 03
What policies and governance exist today?
AI usage policies, approvals, vendor oversight, risk appetite, oversight committees, and documentation compared to emerging healthcare AI governance frameworks.
- 04
How would this look under scrutiny?
How OCR, payers, or buyers would view your AI story if they requested evidence or questioned an AI-influenced decision.
- AI documentation assistants used with PHI but never brought through formal policy or risk review.
- Vendors enabling new AI features in PHI workflows without returning to security, compliance, or legal.
- Staff using public AI tools for drafts that include sensitive operational or patient information.
- No clear owner for AI-related governance decisions; everyone assumes someone else is watching it.
Deliverables you can defend
By the end of the review, you receive three concise artifacts:
AI usage inventory
A practical register of where AI shows up across your organization: internal initiatives, vendor tools, and unsanctioned “shadow AI” that touches PHI or critical workflows.
Policy and documentation gap summary
A plain-language summary of where your current policies, BAAs, and governance processes do — and do not — cover AI-enabled tools, mapped to recognized healthcare AI governance recommendations and the NIST AI Risk Management Framework functions (Govern, Map, Measure, Manage).
Governance and risk recommendations
A prioritized list of governance actions: policy updates, committee structures, documentation improvements, AI-specific risk assessments, and vendor expectations that will matter to OCR, payers, and buyers over the next 12–24 months.
These are written for executives and boards first, with enough structure for compliance, security, and IT teams to execute.
Short, defined engagement — not an open-ended audit
Most reviews complete within 3–4 weeks:
- Discovery (week 1)
One 60–90 minute working session with your executive sponsor and key stakeholders, plus a light evidence request (AI-related policies, key vendor list, known AI use).
- Assessment (weeks 1–3)
Targeted interviews around AI use cases in clinical, operational, and back-office workflows, and a high-level comparison against emerging healthcare AI governance frameworks and regulatory expectations.
- Executive read-out (week 3 or 4)
A 60–90 minute session walking through the inventory, gaps, and governance recommendations, plus a written summary suitable for your board, AI governance committee, or diligence teams.
If CareNorth becomes the right long-term fit, this review can be credited toward your first month of ongoing leadership services, so it becomes phase one of your broader governance program, not a one-off.
Is your AI story ready for scrutiny?
If your teams or vendors are already using AI — even informally — you want a clear, defensible answer when regulators, payers, or buyers ask how it is governed. A 60–90 minute working session is the cleanest way to map your current AI risk picture and decide whether the Readiness Review is the right next step.
Founder-led. You reach the person responsible for the engagement.